93 related articles for article (PubMed ID: 17105913)
21. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
[TBL] [Abstract][Full Text] [Related]
22. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
[TBL] [Abstract][Full Text] [Related]
23. Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.
McFadden LM; Vieira-Brock PL; Hanson GR; Fleckenstein AE
Neuropharmacology; 2015 Jun; 93():146-54. PubMed ID: 25645392
[TBL] [Abstract][Full Text] [Related]
24. Effects of L-carnitine pretreatment in methamphetamine and 3-nitropropionic acid-induced neurotoxicity.
Binienda ZK; Przybyla BD; Robinson BL; Salem N; Virmani A; Amato A; Ali SF
Ann N Y Acad Sci; 2006 Aug; 1074():74-83. PubMed ID: 17105904
[TBL] [Abstract][Full Text] [Related]
25. Methamphetamine self-administration acutely decreases monoaminergic transporter function.
McFadden LM; Stout KA; Vieira-Brock PL; Allen SC; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
Synapse; 2012 Mar; 66(3):240-5. PubMed ID: 22120988
[TBL] [Abstract][Full Text] [Related]
26. Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite.
Brown JM; Quinton MS; Yamamoto BK
J Neurochem; 2005 Oct; 95(2):429-36. PubMed ID: 16086684
[TBL] [Abstract][Full Text] [Related]
27. Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats.
Pereira FC; Lourenço E; Milhazes N; Morgadinho T; Ribeiro CF; Ali SF; Macedo TR
Ann N Y Acad Sci; 2006 Aug; 1074():160-73. PubMed ID: 17105914
[TBL] [Abstract][Full Text] [Related]
28. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse.
Anderson KL; Itzhak Y
Ann N Y Acad Sci; 2006 Aug; 1074():225-33. PubMed ID: 17105919
[TBL] [Abstract][Full Text] [Related]
29. A novel molecule 'shati' increases dopamine uptake via the induction of tumor necrosis factor-alpha in pheochromocytoma-12 cells.
Niwa M; Nitta A; Cen X; Kitaichi K; Ozaki N; Yamada K; Nabeshima T
J Neurochem; 2008 Dec; 107(6):1697-708. PubMed ID: 19014384
[TBL] [Abstract][Full Text] [Related]
30. The methamphetamine experience: a NIDA partnership.
Hanson GR; Rau KS; Fleckenstein AE
Neuropharmacology; 2004; 47 Suppl 1():92-100. PubMed ID: 15464128
[TBL] [Abstract][Full Text] [Related]
31. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.
Volz TJ; Fleckenstein AE; Hanson GR
Addiction; 2007 Apr; 102 Suppl 1():44-8. PubMed ID: 17493052
[TBL] [Abstract][Full Text] [Related]
32. Differential response of neurotensin to methamphetamine self-administration.
Frankel PS; Hoonakker AJ; Hanson GR
Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
[TBL] [Abstract][Full Text] [Related]
33. Escalating dose, multiple binge methamphetamine regimen does not impair recognition memory in rats.
Clark RE; Kuczenski R; Segal DS
Synapse; 2007 Jul; 61(7):515-22. PubMed ID: 17415795
[TBL] [Abstract][Full Text] [Related]
34. Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n-3 fatty acid dietary deficiency.
Kuperstein F; Eilam R; Yavin E
J Neurochem; 2008 Jul; 106(2):662-71. PubMed ID: 18410511
[TBL] [Abstract][Full Text] [Related]
35. Differential regional effects of methamphetamine on dopamine transport.
Chu PW; Seferian KS; Birdsall E; Truong JG; Riordan JA; Metcalf CS; Hanson GR; Fleckenstein AE
Eur J Pharmacol; 2008 Aug; 590(1-3):105-10. PubMed ID: 18599036
[TBL] [Abstract][Full Text] [Related]
36. Sex differences in dopamine- and vesicular monoamine-transporter functions.
Dluzen DE; McDermott JL
Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858
[TBL] [Abstract][Full Text] [Related]
37. Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release.
Chu PW; Hadlock GC; Vieira-Brock P; Stout K; Hanson GR; Fleckenstein AE
J Neurochem; 2010 Oct; 115(2):325-32. PubMed ID: 20649837
[TBL] [Abstract][Full Text] [Related]
38. Effects of methamphetamine on the cerebellar cortex: a preliminary study.
Ferrucci M; Busceti CL; Falleni A; Giorgi FS; Ruggieri S; Fornai F
Ann N Y Acad Sci; 2006 Aug; 1074():149-53. PubMed ID: 17105912
[TBL] [Abstract][Full Text] [Related]
39. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P
Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439
[TBL] [Abstract][Full Text] [Related]
40. Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity.
Ajjimaporn A; Shavali S; Ebadi M; Govitrapong P
Brain Res Bull; 2008 Dec; 77(6):361-6. PubMed ID: 18852031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
